Finance Income, net was $1.0 million for the three months ended March 31, 2025, compared to $0.7 million in the same period of 2024, representing an increase of $0.3 million, primarily attributable to ...

In recent years, the therapeutic landscape for hematological malignancies has undergone a profound transformation, driven by ...

Scientists have created a new type of super-strong antibody that could significantly enhance cancer immunotherapy. In an ...

Chikungunya virus (CHIKV) is a mosquito-borne pathogen that has been identified in more than 110 countries around the world. The virus typically causes flu-like symptoms, but it can also trigger ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.

By studying Chikungunya virus, scientists shed light on how immune responses to viral infections may lead to persistent symptoms of autoimmune disease.

MIT researchers found a way to measure cell density quickly and accurately — measuring up to 30,000 cells in a single hour. They also showed density changes could be used to make useful predictions, ...

Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools.

As people age, their immune systems become less efficient, posing a challenge for cancer therapies that rely on harnessing immune cells.

Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

Sunshine may hold healing rays for a variety of autoimmune diseases such as multiple sclerosis. Scientists are turning this ...

Oncolytic viruses trigger immunogenic cell death in tumors, releasing signals that activate innate immune cells and promote tumor-specific T-cell responses. While some oncolytic viruses, including FDA ...